Cargando…
Liver Transplant Oncology: Towards Dynamic Tumor-Biology-Oriented Patient Selection
While liver transplantation was initially considered as a curative treatment modality only for hepatocellular carcinoma, the indication has been increasingly extended to other tumor entities over recent years, most recently to the treatment of non-resectable colorectal liver metastases. Although onc...
Autores principales: | Ilmer, Matthias, Guba, Markus Otto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179475/ https://www.ncbi.nlm.nih.gov/pubmed/35681642 http://dx.doi.org/10.3390/cancers14112662 |
Ejemplares similares
-
Textbook outcome in hepato-pancreato-biliary surgery: systematic review
por: Pretzsch, Elise, et al.
Publicado: (2022) -
Center volume, competition, and outcome in German liver transplant centers
por: Guba, Markus
Publicado: (2014) -
Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria
por: Amado, Víctor, et al.
Publicado: (2018) -
The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary Complications
por: Wirth, Ulrich, et al.
Publicado: (2023) -
Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology
por: Gringeri, Enrico, et al.
Publicado: (2020)